Industry Research Reports

Home > Reports > Pharma & Healthcare > Dry Eye Medication - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Dry Eye Medication - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-11

Pages: 130 Pages

Report ld: 2622772

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.

The global market for Dry Eye Medication was estimated to be worth US$ 8579 million in 2023 and is forecast to a readjusted size of US$ 10890 million by 2030 with a CAGR of 3.4% during the forecast period 2024-2030

Dry Eye Medication Market Size

M= millions and B=billions

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Dry Eye Medication, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Dry Eye Medication by region & country, by Type, and by Application.

The Dry Eye Medication market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dry Eye Medication.

Market Segmentation

Report Metric
Details
Report Title
Dry Eye Medication - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 10890 million
CAGR(2024-2030)
3.4%
Market Size Available for Years
2019-2030
Global Dry Eye Medication Companies Covered
EyeGate Pharmaceuticals, Allergan, Novartis, Merck, Santen Pharmaceutical, Shire, Alcon, Bausch Health Companies, Johnson and Johnson, VISUfarma
Global Dry Eye Medication Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Dry Eye Medication Market, Segment by Type
Anti-inflammatory Drugs

Artificial Tears

Punctal Plugs

Secretagogues

Others
Global Dry Eye Medication Market, Segment by Application
Hospital

Pharmacies

Eye Health Clinics

Retail Pharmacies

Online Pharmacies
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Dry Eye Medication manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Dry Eye Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Dry Eye Medication in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Dry Eye Medication Product Introduction
    1.2 Global Dry Eye Medication Market Size Forecast
        1.2.1 Global Dry Eye Medication Sales Value (2019-2030)
        1.2.2 Global Dry Eye Medication Sales Volume (2019-2030)
        1.2.3 Global Dry Eye Medication Sales Price (2019-2030)
    1.3 Dry Eye Medication Market Trends & Drivers
        1.3.1 Dry Eye Medication Industry Trends
        1.3.2 Dry Eye Medication Market Drivers & Opportunity
        1.3.3 Dry Eye Medication Market Challenges
        1.3.4 Dry Eye Medication Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Dry Eye Medication Players Revenue Ranking (2023)
    2.2 Global Dry Eye Medication Revenue by Company (2019-2024)
    2.3 Global Dry Eye Medication Players Sales Volume Ranking (2023)
    2.4 Global Dry Eye Medication Sales Volume by Company Players (2019-2024)
    2.5 Global Dry Eye Medication Average Price by Company (2019-2024)
    2.6 Key Manufacturers Dry Eye Medication Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Dry Eye Medication Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Dry Eye Medication
    2.9 Dry Eye Medication Market Competitive Analysis
        2.9.1 Dry Eye Medication Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Dry Eye Medication Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Eye Medication as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Anti-inflammatory Drugs
        3.1.2 Artificial Tears
        3.1.3 Punctal Plugs
        3.1.4 Secretagogues
        3.1.5 Others
    3.2 Global Dry Eye Medication Sales Value by Type
        3.2.1 Global Dry Eye Medication Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Dry Eye Medication Sales Value, by Type (2019-2030)
        3.2.3 Global Dry Eye Medication Sales Value, by Type (%) (2019-2030)
    3.3 Global Dry Eye Medication Sales Volume by Type
        3.3.1 Global Dry Eye Medication Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Dry Eye Medication Sales Volume, by Type (2019-2030)
        3.3.3 Global Dry Eye Medication Sales Volume, by Type (%) (2019-2030)
    3.4 Global Dry Eye Medication Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospital
        4.1.2 Pharmacies
        4.1.3 Eye Health Clinics
        4.1.4 Retail Pharmacies
        4.1.5 Online Pharmacies
    4.2 Global Dry Eye Medication Sales Value by Application
        4.2.1 Global Dry Eye Medication Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Dry Eye Medication Sales Value, by Application (2019-2030)
        4.2.3 Global Dry Eye Medication Sales Value, by Application (%) (2019-2030)
    4.3 Global Dry Eye Medication Sales Volume by Application
        4.3.1 Global Dry Eye Medication Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Dry Eye Medication Sales Volume, by Application (2019-2030)
        4.3.3 Global Dry Eye Medication Sales Volume, by Application (%) (2019-2030)
    4.4 Global Dry Eye Medication Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Dry Eye Medication Sales Value by Region
        5.1.1 Global Dry Eye Medication Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Dry Eye Medication Sales Value by Region (2019-2024)
        5.1.3 Global Dry Eye Medication Sales Value by Region (2025-2030)
        5.1.4 Global Dry Eye Medication Sales Value by Region (%), (2019-2030)
    5.2 Global Dry Eye Medication Sales Volume by Region
        5.2.1 Global Dry Eye Medication Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Dry Eye Medication Sales Volume by Region (2019-2024)
        5.2.3 Global Dry Eye Medication Sales Volume by Region (2025-2030)
        5.2.4 Global Dry Eye Medication Sales Volume by Region (%), (2019-2030)
    5.3 Global Dry Eye Medication Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Dry Eye Medication Sales Value, 2019-2030
        5.4.2 North America Dry Eye Medication Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Dry Eye Medication Sales Value, 2019-2030
        5.5.2 Europe Dry Eye Medication Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Dry Eye Medication Sales Value, 2019-2030
        5.6.2 Asia Pacific Dry Eye Medication Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Dry Eye Medication Sales Value, 2019-2030
        5.7.2 South America Dry Eye Medication Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Dry Eye Medication Sales Value, 2019-2030
        5.8.2 Middle East & Africa Dry Eye Medication Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Dry Eye Medication Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Dry Eye Medication Sales Value
        6.2.1 Key Countries/Regions Dry Eye Medication Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Dry Eye Medication Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Dry Eye Medication Sales Value, 2019-2030
        6.3.2 United States Dry Eye Medication Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Dry Eye Medication Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Dry Eye Medication Sales Value, 2019-2030
        6.4.2 Europe Dry Eye Medication Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Dry Eye Medication Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Dry Eye Medication Sales Value, 2019-2030
        6.5.2 China Dry Eye Medication Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Dry Eye Medication Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Dry Eye Medication Sales Value, 2019-2030
        6.6.2 Japan Dry Eye Medication Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Dry Eye Medication Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Dry Eye Medication Sales Value, 2019-2030
        6.7.2 South Korea Dry Eye Medication Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Dry Eye Medication Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Dry Eye Medication Sales Value, 2019-2030
        6.8.2 Southeast Asia Dry Eye Medication Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Dry Eye Medication Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Dry Eye Medication Sales Value, 2019-2030
        6.9.2 India Dry Eye Medication Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Dry Eye Medication Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 EyeGate Pharmaceuticals
        7.1.1 EyeGate Pharmaceuticals Company Information
        7.1.2 EyeGate Pharmaceuticals Introduction and Business Overview
        7.1.3 EyeGate Pharmaceuticals Dry Eye Medication Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 EyeGate Pharmaceuticals Dry Eye Medication Product Offerings
        7.1.5 EyeGate Pharmaceuticals Recent Development
    7.2 Allergan
        7.2.1 Allergan Company Information
        7.2.2 Allergan Introduction and Business Overview
        7.2.3 Allergan Dry Eye Medication Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Allergan Dry Eye Medication Product Offerings
        7.2.5 Allergan Recent Development
    7.3 Novartis
        7.3.1 Novartis Company Information
        7.3.2 Novartis Introduction and Business Overview
        7.3.3 Novartis Dry Eye Medication Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Novartis Dry Eye Medication Product Offerings
        7.3.5 Novartis Recent Development
    7.4 Merck
        7.4.1 Merck Company Information
        7.4.2 Merck Introduction and Business Overview
        7.4.3 Merck Dry Eye Medication Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Merck Dry Eye Medication Product Offerings
        7.4.5 Merck Recent Development
    7.5 Santen Pharmaceutical
        7.5.1 Santen Pharmaceutical Company Information
        7.5.2 Santen Pharmaceutical Introduction and Business Overview
        7.5.3 Santen Pharmaceutical Dry Eye Medication Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Santen Pharmaceutical Dry Eye Medication Product Offerings
        7.5.5 Santen Pharmaceutical Recent Development
    7.6 Shire
        7.6.1 Shire Company Information
        7.6.2 Shire Introduction and Business Overview
        7.6.3 Shire Dry Eye Medication Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Shire Dry Eye Medication Product Offerings
        7.6.5 Shire Recent Development
    7.7 Alcon
        7.7.1 Alcon Company Information
        7.7.2 Alcon Introduction and Business Overview
        7.7.3 Alcon Dry Eye Medication Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Alcon Dry Eye Medication Product Offerings
        7.7.5 Alcon Recent Development
    7.8 Bausch Health Companies
        7.8.1 Bausch Health Companies Company Information
        7.8.2 Bausch Health Companies Introduction and Business Overview
        7.8.3 Bausch Health Companies Dry Eye Medication Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Bausch Health Companies Dry Eye Medication Product Offerings
        7.8.5 Bausch Health Companies Recent Development
    7.9 Johnson and Johnson
        7.9.1 Johnson and Johnson Company Information
        7.9.2 Johnson and Johnson Introduction and Business Overview
        7.9.3 Johnson and Johnson Dry Eye Medication Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Johnson and Johnson Dry Eye Medication Product Offerings
        7.9.5 Johnson and Johnson Recent Development
    7.10 VISUfarma
        7.10.1 VISUfarma Company Information
        7.10.2 VISUfarma Introduction and Business Overview
        7.10.3 VISUfarma Dry Eye Medication Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 VISUfarma Dry Eye Medication Product Offerings
        7.10.5 VISUfarma Recent Development

 8 Industry Chain Analysis
    8.1 Dry Eye Medication Industrial Chain
    8.2 Dry Eye Medication Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Dry Eye Medication Sales Model
        8.5.2 Sales Channel
        8.5.3 Dry Eye Medication Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Dry Eye Medication Market Trends
    Table 2. Dry Eye Medication Market Drivers & Opportunity
    Table 3. Dry Eye Medication Market Challenges
    Table 4. Dry Eye Medication Market Restraints
    Table 5. Global Dry Eye Medication Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Dry Eye Medication Revenue Market Share by Company (2019-2024)
    Table 7. Global Dry Eye Medication Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Dry Eye Medication Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Dry Eye Medication Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Dry Eye Medication Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Dry Eye Medication Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Dry Eye Medication
    Table 13. Global Dry Eye Medication Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Eye Medication as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Dry Eye Medication Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Dry Eye Medication Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Dry Eye Medication Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Dry Eye Medication Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Dry Eye Medication Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Dry Eye Medication Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Dry Eye Medication Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Dry Eye Medication Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Dry Eye Medication Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Dry Eye Medication Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Dry Eye Medication Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Dry Eye Medication Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Dry Eye Medication Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Dry Eye Medication Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Dry Eye Medication Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Dry Eye Medication Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Dry Eye Medication Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Dry Eye Medication Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Dry Eye Medication Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Dry Eye Medication Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Dry Eye Medication Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Dry Eye Medication Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Dry Eye Medication Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Dry Eye Medication Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Dry Eye Medication Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Dry Eye Medication Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Dry Eye Medication Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Dry Eye Medication Sales Value by Region (2019-2024) & (%)
    Table 44. Global Dry Eye Medication Sales Value by Region (2025-2030) & (%)
    Table 45. Global Dry Eye Medication Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Dry Eye Medication Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Dry Eye Medication Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Dry Eye Medication Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Dry Eye Medication Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Dry Eye Medication Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Dry Eye Medication Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Dry Eye Medication Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Dry Eye Medication Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Dry Eye Medication Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Dry Eye Medication Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Dry Eye Medication Sales Volume, (2025-2030) & (K Units)
    Table 57. EyeGate Pharmaceuticals Company Information
    Table 58. EyeGate Pharmaceuticals Introduction and Business Overview
    Table 59. EyeGate Pharmaceuticals Dry Eye Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. EyeGate Pharmaceuticals Dry Eye Medication Product Offerings
    Table 61. EyeGate Pharmaceuticals Recent Development
    Table 62. Allergan Company Information
    Table 63. Allergan Introduction and Business Overview
    Table 64. Allergan Dry Eye Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Allergan Dry Eye Medication Product Offerings
    Table 66. Allergan Recent Development
    Table 67. Novartis Company Information
    Table 68. Novartis Introduction and Business Overview
    Table 69. Novartis Dry Eye Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Novartis Dry Eye Medication Product Offerings
    Table 71. Novartis Recent Development
    Table 72. Merck Company Information
    Table 73. Merck Introduction and Business Overview
    Table 74. Merck Dry Eye Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Merck Dry Eye Medication Product Offerings
    Table 76. Merck Recent Development
    Table 77. Santen Pharmaceutical Company Information
    Table 78. Santen Pharmaceutical Introduction and Business Overview
    Table 79. Santen Pharmaceutical Dry Eye Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Santen Pharmaceutical Dry Eye Medication Product Offerings
    Table 81. Santen Pharmaceutical Recent Development
    Table 82. Shire Company Information
    Table 83. Shire Introduction and Business Overview
    Table 84. Shire Dry Eye Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Shire Dry Eye Medication Product Offerings
    Table 86. Shire Recent Development
    Table 87. Alcon Company Information
    Table 88. Alcon Introduction and Business Overview
    Table 89. Alcon Dry Eye Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Alcon Dry Eye Medication Product Offerings
    Table 91. Alcon Recent Development
    Table 92. Bausch Health Companies Company Information
    Table 93. Bausch Health Companies Introduction and Business Overview
    Table 94. Bausch Health Companies Dry Eye Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Bausch Health Companies Dry Eye Medication Product Offerings
    Table 96. Bausch Health Companies Recent Development
    Table 97. Johnson and Johnson Company Information
    Table 98. Johnson and Johnson Introduction and Business Overview
    Table 99. Johnson and Johnson Dry Eye Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Johnson and Johnson Dry Eye Medication Product Offerings
    Table 101. Johnson and Johnson Recent Development
    Table 102. VISUfarma Company Information
    Table 103. VISUfarma Introduction and Business Overview
    Table 104. VISUfarma Dry Eye Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. VISUfarma Dry Eye Medication Product Offerings
    Table 106. VISUfarma Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. Dry Eye Medication Downstream Customers
    Table 110. Dry Eye Medication Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Dry Eye Medication Product Picture
    Figure 2. Global Dry Eye Medication Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Dry Eye Medication Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Dry Eye Medication Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Dry Eye Medication Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Dry Eye Medication Report Years Considered
    Figure 7. Global Dry Eye Medication Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Dry Eye Medication Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Dry Eye Medication Revenue in 2023
    Figure 10. Dry Eye Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Anti-inflammatory Drugs Picture
    Figure 12. Artificial Tears Picture
    Figure 13. Punctal Plugs Picture
    Figure 14. Secretagogues Picture
    Figure 15. Others Picture
    Figure 16. Global Dry Eye Medication Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Dry Eye Medication Sales Value Market Share by Type, 2023 & 2030
    Figure 18. Global Dry Eye Medication Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 19. Global Dry Eye Medication Sales Volume Market Share by Type, 2023 & 2030
    Figure 20. Global Dry Eye Medication Price by Type (2019-2030) & (US$/Unit)
    Figure 21. Product Picture of Hospital
    Figure 22. Product Picture of Pharmacies
    Figure 23. Product Picture of Eye Health Clinics
    Figure 24. Product Picture of Retail Pharmacies
    Figure 25. Product Picture of Online Pharmacies
    Figure 26. Global Dry Eye Medication Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 27. Global Dry Eye Medication Sales Value Market Share by Application, 2023 & 2030
    Figure 28. Global Dry Eye Medication Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 29. Global Dry Eye Medication Sales Volume Market Share by Application, 2023 & 2030
    Figure 30. Global Dry Eye Medication Price by Application (2019-2030) & (US$/Unit)
    Figure 31. North America Dry Eye Medication Sales Value (2019-2030) & (US$ Million)
    Figure 32. North America Dry Eye Medication Sales Value by Country (%), 2023 VS 2030
    Figure 33. Europe Dry Eye Medication Sales Value (2019-2030) & (US$ Million)
    Figure 34. Europe Dry Eye Medication Sales Value by Country (%), 2023 VS 2030
    Figure 35. Asia Pacific Dry Eye Medication Sales Value (2019-2030) & (US$ Million)
    Figure 36. Asia Pacific Dry Eye Medication Sales Value by Country (%), 2023 VS 2030
    Figure 37. South America Dry Eye Medication Sales Value (2019-2030) & (US$ Million)
    Figure 38. South America Dry Eye Medication Sales Value by Country (%), 2023 VS 2030
    Figure 39. Middle East & Africa Dry Eye Medication Sales Value (2019-2030) & (US$ Million)
    Figure 40. Middle East & Africa Dry Eye Medication Sales Value by Country (%), 2023 VS 2030
    Figure 41. Key Countries/Regions Dry Eye Medication Sales Value (%), (2019-2030)
    Figure 42. Key Countries/Regions Dry Eye Medication Sales Volume (%), (2019-2030)
    Figure 43. United States Dry Eye Medication Sales Value, (2019-2030) & (US$ Million)
    Figure 44. United States Dry Eye Medication Sales Value by Type (%), 2023 VS 2030
    Figure 45. United States Dry Eye Medication Sales Value by Application (%), 2023 VS 2030
    Figure 46. Europe Dry Eye Medication Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Europe Dry Eye Medication Sales Value by Type (%), 2023 VS 2030
    Figure 48. Europe Dry Eye Medication Sales Value by Application (%), 2023 VS 2030
    Figure 49. China Dry Eye Medication Sales Value, (2019-2030) & (US$ Million)
    Figure 50. China Dry Eye Medication Sales Value by Type (%), 2023 VS 2030
    Figure 51. China Dry Eye Medication Sales Value by Application (%), 2023 VS 2030
    Figure 52. Japan Dry Eye Medication Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Japan Dry Eye Medication Sales Value by Type (%), 2023 VS 2030
    Figure 54. Japan Dry Eye Medication Sales Value by Application (%), 2023 VS 2030
    Figure 55. South Korea Dry Eye Medication Sales Value, (2019-2030) & (US$ Million)
    Figure 56. South Korea Dry Eye Medication Sales Value by Type (%), 2023 VS 2030
    Figure 57. South Korea Dry Eye Medication Sales Value by Application (%), 2023 VS 2030
    Figure 58. Southeast Asia Dry Eye Medication Sales Value, (2019-2030) & (US$ Million)
    Figure 59. Southeast Asia Dry Eye Medication Sales Value by Type (%), 2023 VS 2030
    Figure 60. Southeast Asia Dry Eye Medication Sales Value by Application (%), 2023 VS 2030
    Figure 61. India Dry Eye Medication Sales Value, (2019-2030) & (US$ Million)
    Figure 62. India Dry Eye Medication Sales Value by Type (%), 2023 VS 2030
    Figure 63. India Dry Eye Medication Sales Value by Application (%), 2023 VS 2030
    Figure 64. Dry Eye Medication Industrial Chain
    Figure 65. Dry Eye Medication Manufacturing Cost Structure
    Figure 66. Channels of Distribution (Direct Sales, and Distribution)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed

Description

Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.

The global market for Dry Eye Medication was estimated to be worth US$ 8579 million in 2023 and is forecast to a readjusted size of US$ 10890 million by 2030 with a CAGR of 3.4% during the forecast period 2024-2030

Market Segmentation